|
|
 |
| TCTAP 2017 Press Kit |
 |
| TCTAP 2016 Final Program |
|
| Introduction of CVRF |
|
|
 |
|
| TCTAP 2016 Sponsor |
AstraZeneca Korea  |
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cardiovascular, cancer, gastrointestinal, infection.
Booth No. A004
|
| Evening Symposium |
| Address the CAD Challenge; The Future of Antiplatelet Therapy |
| Organized by CVRF and Supported by Educational Grant from AstraZeneca Korea |
Wednesday, April 27
6:00 PM - 7:30 PM
The Latest Update "Presentation Theater", Level 1 |
| Moderator(s): In-Ho Chae, Myung-Ho Jeong | | Panelist(s): Jang-Whan Bae, Jung Ho Heo, Neal S. Kleiman, Sung Uk Kwon, Sang-Rok Lee, Chang-Wook Nam, Keun-Ho Park, Young Jin Youn | |
| 6:00 PM |
Opening Remarks
Speaker : Myung-Ho Jeong
|
| 6:10 PM |
The Future PROSPECT for the Role of Antiplatelet Therapy
Lecturer : Gregg W. Stone
|
| 6:25 PM |
Optimal Initiation and Duration of DAPT in ACS Patient; Reviewing the Evidence of Ticagrelor
Lecturer : Roxana Mehran
|
| 6:40 PM |
Selecting the Appropriate Patients for Long-Term DAPT; Insights from Latest Trials
Lecturer : David Joel Cohen
|
| 7:00 PM |
Panel Discussion
|
| 7:25 PM |
Summary & Closing
Speaker : In-Ho Chae
|
|
|
|
| Lunchtime Activities |
| Evolution of Antiplatelet Treatment in ACS and Stable CAD |
| Organized by CVRF and Supported by Educational Grant from AstraZeneca Korea |
Thursday, April 28
12:45 PM - 1:45 PM
Endovascular Theater, Level 1 |
| Moderator(s): Yangsoo Jang, Seung-Jea Tahk | | Panelist(s): Seung-Ho Hur, Hyun-Jae Kang, June Hong Kim, Neal S. Kleiman, Yoon Seok Koh, Byoung Kwon Lee, Sang Min Park, Seung-Woon Rha | |
| 12:45 PM |
Opening Remarks
Speaker : Seung-Jea Tahk
|
| 12:50 PM |
Upcoming Trend in ACS Patient Management
Lecturer : Roxana Mehran
|
| 1:05 PM |
Panel Discussion
|
| 1:15 PM |
Optimizing Antiplatelet Therapy: Balancing Ischemic & Bleeding Risks
Lecturer : David Joel Cohen
|
| 1:30 PM |
Panel Discussion
|
| 1:40 PM |
Summary & Closing
Speaker : Yangsoo Jang
|
|
|
|
|
|
